Acadia Pharmaceuticals (ACAD) Q4 Earnings Lag Estimates
Portfolio Pulse from
Acadia Pharmaceuticals (ACAD) reported Q4 earnings of $0.17 per share, missing the Zacks Consensus Estimate of $0.19 per share and down from $0.28 per share a year ago.
February 26, 2025 | 11:45 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Acadia Pharmaceuticals reported Q4 earnings of $0.17 per share, missing the Zacks Consensus Estimate of $0.19 and showing a decline from $0.28 per share a year ago.
The earnings miss and year-over-year decline in earnings per share are likely to negatively impact investor sentiment and the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100